|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Is osteoporosis a peculiar association with primary biliary cirrhosis?显示文摘AIM: (1) To compare the prevalence of osteoporosis (t-score ≤-2.5 SD) between stage Ⅳ PBC patients, and two groups of age- and sex-matched controls: one with hepatitis C virus (HCV)-related cirrhosis, and the other one consisting of a group of healthy subjects from the general population; (2) to identify the main risk factors for the development of bone loss.METHODS: Thirty-five stage Ⅳ PBC patients (mean age 52.5±10 years), 49 females with HCV-related cirrhosis (mean age 52.9±5.8 years) and 33 healthy females (mean age 51.8+2.22 years) were enrolled in the study. Bone metabolism was evaluated by measuring serum calcium corrected for serum albumin (Ca corr.), 25-hydroxy vitamin D (25-OH vit D), parathyroid hormone, osteocalcin.Bone mineral density (BMD) was assessed at the lumbar spine by dual-photon X-ray absorptiometry.RESULTS: Osteoporosis was present in 5/35 PBC patients (14.2%) and in 7/49 HCV-related cirrhotic patients (14.3%),without any statistical difference between the two groups.Among healthy control subjects, none had osteoporosis.No difference was found between the three groups in serum parameters of bone metabolism. Univariate analysis showed that menopausal state and low BMI were significantly correlated with osteoporosis. Multivariate regression analysis showed that menopausal status, BMI <23, and old age were independent variables significantly correlated with osteoporosis.CONCLUSION: PBC in itself has no negative influence on BMD. End-stage liver disease patients carry a disease-specific risk for osteoporosis, but have an effective risk of bone loss in relation to individual potential risk for each patient. A practical message should be taken into account, that is, every effort should be made to prevent osteoporosis when a patient has simple osteopenia, or if it is a woman in or near menopausal age. | Annarosa Floreani Andrea Mega Valentina Camozzi Vincenzo Baldo Mario Plebani Patrizia Burra Giovanni Luisetto | 2005 | World Journal of Gastroenterology2005，11，34： | 7 |
| 2 | The Value of Serial Arteriography in Osteosarcoma: Delivery of Chemotherapy, Determination of Therapy Duration, and Prediction of Necrosis显示文摘 | John W. Cullen Brandt A. Jamroz Sidney L. Stevens Walt Madsen Ioana Hinshaw Ross M. Wilkins Patsy Cullen Anne B. Camozzi Kyle Fink Sandford D. Peck Cynthia M. Kelly | 2005 | Journal of Vascular and Interventional Radiology2005，，8： | 1 |
| 3 | Skin biopsy for the diagnosis of peripheral neuropathy 显示文摘 | Lauria G Lombardi R Camozzi F | 2009 | Histopathology2009，54，3： | 1 |
| 4 | Superior Survival in Treatment of Primary Nonmetastatic Pediatric Osteosarcoma of the Extremity显示文摘 | Ross M. Wilkins MD John W. Cullen MD Lorrie Odom MD Brandt A. Jamroz MD Patsy McGuire Cullen MS CPNP Kyle Fink MD Sanford D. Peck MD Sydney L. Stevens MD Cynthia M. Kelly MD Anne B. Camozzi BA | 2003 | Annals of Surgical Oncology2003，，5： | 1 |
| 5 | Combining lisinopril and 1-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis显示文摘 | Zoja C Benigni A Camozzi D | 2003 | Kidney Int2003，64，3： | 1 |
| 6 | Quantitative bone ul trasound at phalanges and calcanues in osteoporotic postmenopausal women: influence of age and measurement site显示文摘 | Camozzi V De Terlizzi F Zangari M | 2007 | Ultrasound Med Biol2007，33，7： | 1 |
| 7 | Anti-FGF2 ap- proaches as a strategy to compensate resistance to anti- VEGF therapy: long-pentraxin 3 as a novel antiangio- genic FGF2-antagonist显示文摘 | Alessi P Leali D Camozzi M | 2009 | Eur Cytokine Netw2009，20，4： | 1 |
| 8 | Arterial blood pressure,serum calcium and PTH in elderly men with parathyroid tumors and primary hyperparathyroidism显示文摘 | Lumachi F Camozzi V Luisetto G | | 0，，11： | 1 |
| 9 | Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis显示文摘 | Rusnati M Camozzi M Moroni E | 2004 | Blood2004，104，1： | 1 |
| 10 | Improved survival in primary nonmetastatic pediatric osteosarcoma of the extremity 显示文摘 | Wilkins RM Cullen JW Camozzi AB | 2005 | Clin Orthop Relat Res2005，438，： | 1 |
| 11 | Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis 显示文摘 | Lumachi F Ermani M Camozzi V | 2009 | Ann N Y Acad Sci2009，10，7： | 1 |
| 12 | Identification of an antiangiogenic FGF2 - binding site in the N terminus of the soluble pattern recognition receptor PTX3 显示文摘 | Camozzi M Rusnati M Bugatti A | 2006 | Biol Chem2006，281，22： | 1 |
| 13 | Role of biochemical markers of bone remodeling in clinical practice显示文摘 | Camozzi V Tossi A Simoni E | | 0，，6： | 1 |
| 14 | Selective recognition of flbroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis 显示文摘 | Rusnati M Camozzi M Moroni E | 2004 | Blood2004，104，1： | 1 |
| 15 | Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis 显示文摘 | Lumachi F Ermani M Camozzi V | 2009 | Annals of the New York Academy of Sciences2009，1173，1： | 1 |
| 16 | Role of the soluble patternrecognition receptor PTX3 in vascular biology显示文摘 | Presta M Camozzi M Salvatori G | 2007 | J Cell Mol Med2007，11，4： | 1 |
| 17 | Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis显示文摘 | Rusnati M Camozzi M Moroni E | 2004 | Blood2004，104，1： | 1 |
| 18 | Identification of an antiangiogenic FGF2binding site in the N terminus of the soluble pattern recognition receptor PTX3显示文摘 | Camozzi M Rusnat M Bugatti A | 2006 | J Biol Chem2006，281，22： | 1 |
| 19 | How to Fully Protect The Kidney in a Severe Model of Progressive Nephropathy:a Multidrug Approach显示文摘 | ZOJA C CORNA D CAMOZZI D | 2002 | J Am Soc Nephrol(S1046-6673)2002，13，12： | 1 |
| 20 | How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach 显示文摘 | Zoja C Corna D Camozzi D | 2002 | J Am Soc Nephrol2002，13，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员